L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea flag South Korea · Delayed Price · Currency is KRW
53,300
+1,500 (2.90%)
Aug 20, 2026, 3:30 PM KST

L&C BIO Co.,LTD Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-135,144-138,175141,59648,3614,54413,814
Depreciation & Amortization
8,4168,2346,7545,6544,5082,902
Loss (Gain) From Sale of Assets
11.3-92.81278.45-163.01-75.75-42.98
Asset Writedown & Restructuring Costs
72,52072,520-2,423--
Loss (Gain) From Sale of Investments
2,6691,081-140,830-62,1781,74076.02
Loss (Gain) on Equity Investments
278.66195.082,414437.29806.4-3,743
Stock-Based Compensation
539.08270.63149.56138.88375.84727.41
Provision & Write-off of Bad Debts
78.5483.92-722.58399.09-187.79-329.56
Other Operating Activities
71,73470,076-15,59419,2603,6154,692
Change in Accounts Receivable
-7,167-3,149-2,766-5,429-53.77-3,285
Change in Inventory
5,8093,475-1,437-12,151-23,269-4,554
Change in Accounts Payable
1,172-1,906183.95-1,1581,709754.1
Change in Other Net Operating Assets
-1,517-48.41,406-7,728213.3-104.08
Operating Cash Flow
19,39912,565-8,567-12,133-6,07610,907
Operating Cash Flow Growth
-----47.01%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-22,451-15,810-4,715-24,503-37,531-10,251
Sale of Property, Plant & Equipment
2.562.56544.78256.73-120.91
Cash Acquisitions
28,654-14,332-11,678--1,912-
Sale (Purchase) of Intangibles
-1,400-1,225-629.02-421.0813.05-1,137
Investment in Securities
6,838-3,13023,29549,856-43,867-6,240
Other Investing Activities
-28,778237.37-28,422-288.46-265.74-1,911
Investing Cash Flow
-16,298-32,890-21,94624,634-83,633-20,488

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-2,77023,6008,38117,949-
Long-Term Debt Issued
-70,21619,690-71,5936,000
Total Debt Issued
75,28672,98643,2908,38189,5426,000
Short-Term Debt Repaid
--16,360--9,641-8,282-
Long-Term Debt Repaid
--32,004-8,451-1,676-1,271-663.01
Total Debt Repaid
-51,631-48,364-8,451-11,317-9,553-663.01
Net Debt Issued (Repaid)
23,65524,62234,839-2,93679,9895,337
Issuance of Common Stock
18,01717,312----
Repurchase of Common Stock
-10,020-10,020--840--2,048
Dividends Paid
-1,122-1,122-2,268-1,115-1,115-1,078
Other Financing Activities
1,2871,3321,260735.9853.62,487
Financing Cash Flow
31,81732,12333,830-4,15578,9284,697

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
538.3163.7319.611.32-9.19-
Miscellaneous Cash Flow Adjustments
639.18639.18---0
Net Cash Flow
36,09612,6013,3378,357-10,790-4,884

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-3,052-3,245-13,282-36,636-43,607655.69
Free Cash Flow Growth
------85.11%
Free Cash Flow Margin
-3.11%-3.80%-18.44%-55.57%-82.95%1.44%
Free Cash Flow Per Share
-125.53-136.49-585.50-1481.90-1922.2929.41
Levered Free Cash Flow
103,51592,373627.58-24,219-49,766-8,801
Unlevered Free Cash Flow
107,18296,0392,641-20,361-47,843-8,513

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,6521,859497.63530.96158.6923.01
Cash Income Tax Paid
173.15-282.5814,8701,2211,247-514.3
Change in Working Capital
-1,703-1,628-2,613-26,466-21,401-7,190